Neo-Terramycin 50/50D
This page contains information on Neo-Terramycin 50/50D for veterinary use.The information provided typically includes the following:
- Neo-Terramycin 50/50D Indications
- Warnings and cautions for Neo-Terramycin 50/50D
- Direction and dosage information for Neo-Terramycin 50/50D
Neo-terramycin 50/50d
This treatment applies to the following species:(neomycin-oxytetracycline)
Type A Medicated Article
(antibiotic)
Active Drug Ingredients
|
Oxytetracycline (from oxytetracycline dihydrate) |
50 g/lb |
|
Neomycin Sulfate |
50 g/lb |
Neo-Terramycin 50/50D Caution
For use in manufacturing medicated animal feeds only.Neo-Terramycin 50/50D Caution
Certain components of animal feeds, including medicated premixes, possess properties that may be a potential health hazard or a source of personal discomfort to certain individuals who are exposed to them. Human exposure should, therefore, be minimized by observing the general industry standards for occupational health and safety.Precautions such as the following should be considered: dust masks or respirators and protective clothing should be worn; dust-arresting equipment and adequate ventilation should be utilized; personal hygiene should be observed; wash before eating or leaving a work site; be alert for signs of allergic reactions-seek prompt medical treatment if such reactions are suspected.
For Use In Dry Feeds Only. Not For Use In Liquid Feed Supplements.
Mixing And Use Directions
Mix Neo-Terramycin 50/50D with nonmedicated milk replacer to provide the following drug concentrations:
Neo-Terramycin 50/50D Indications For Use |
Oxytetracycline And Neomycin Amount |
Lb. Of Neo-terramycin 50/50d Per Ton1
|
|
calves (milk Replacer) |
||
|
For calves (up to 250 lb) for increased rate of weight gain and improved feed efficiency |
0.05-0.1 mg/lb of body weight daily |
0.2-0.42 |
|
For calves (up to 250 lb) for treatment of bacterial enteritis caused by E. coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin |
10 mg/lb of body weight daily |
402 |
Calves, Beef Cattle, And Nonlactating Dairy Cattle |
||
|
Treatment of bacterial enteritis caused by E. coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin |
10 mg/lb of body weight daily |
402 |
 |
Warning: A Withdrawal Period Has Not Been Established In Preruminating Calves; Do Not Use In Calves To Be Processed For Veal. At The 10 Mg/lb Level, Withdraw 5 Days Before Slaughter.Use Of More Than One Product Containing Neomycin Or Failure To Follow Withdrawal Times May Result In Illegal Drug Residues.A Milk Discard Time Has Not Been Established For Use In Lactating Dairy Cattle. Do Not Use In Female Dairy Cattle 20 Months Of Age Or Older. |
 |
1Mixing directions are for example only and are based on mixing 1 lb of dry milk replacer with 1 gallon of water.
2If calf weighs 100 lb, consuming 1 gallon of milk replacer per day.
For Use In Animal Feeds Only
Not For Human Use
Restricted Drug (california) - Use Only As Directed
Store In A Dry, Cool Place
Neo-terramycin Is A Registered Trademark Of Pfizer, Inc., Licensed To Phibro Animal Health, For Neomycin-oxytetracycline Combination Products.
NADA #94-975, Approved by FDA
Distributed by: Phibro ANIMAL HEALTH, Ridgefield Park, NJ 07660
|
Net Weight |
|
|
|
50 lb (22.7 kg) |
8868000 |
101-9032-06 |
Nac No.
36930081GLENPOINTE CENTRE EAST, 300 FRANK W. BURR BOULEVARD, SUITE #21, TEANECK, NJ, 07666
| Telephone: | 201-329-7300 | |
| Customer Service: | 888-403-0074 | |
| Fax: | 201-329-7070 | |
| Website: | www.pahc.com |
 |
Every effort has been made to ensure the accuracy of the Neo-Terramycin 50/50D information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert. |
Copyright © 2013 North American Compendiums. Updated: 2013-05-17
